Syncona
Overview
Syncona is a London-based, publicly traded healthcare investment firm focused on founding, building, and scaling global life science companies to deliver transformational treatments for patients in areas of high unmet need.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| OMass Therapeutics | Oct 2026 | Series C | Co-investor |
| Re-Aim Therapeutics | May 2026 | Seed | Lead |
| ALTx Therapeutics | Feb 2026 | Accelerator | Co-investor |
| Beacon Therapeutics | Jan 2026 | Series C | Co-investor |
| Apini Therapeutics | Jun 2025 | Seed | Co-investor |
For institutional investors. Book with your work email.
Key People
Elisa Petris
Managing Partner
Roel Bulthuis
Managing Partner
Ben Woolven
Business Strategy And Operations Partner
Hitesh Thakrar
Partner
Gonzalo Garcia
Principal
Alex Hamilton
Investor
Michael Kyriakides
Life Sciences Company Builder And Investor
Usman Sherani
Investor Relations Corporate Communications And Sustainability Associate
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Syncona based?
Syncona is headquartered in London, United Kingdom.
When was Syncona founded?
Syncona was founded in 2012.
How many portfolio companies does Syncona have?
Syncona has 19 portfolio companies in Caplight's dataset.
What are some companies in Syncona's portfolio?
Recent investments visible on Caplight include OMass Therapeutics, Re-Aim Therapeutics, ALTx Therapeutics, Beacon Therapeutics, Apini Therapeutics.
What was Syncona's most recent investment?
Syncona's most recent investment on Caplight was in OMass Therapeutics in 2026.
What sectors does Syncona focus on?
Syncona focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences.
What company stages does Syncona focus on?
Syncona typically invests at the Early stage.
What is Syncona's AUM?
Syncona's assets under management are estimated between $1.2B and $1.3B.